(a) This chapter does not expand the coverage required of an insurer.
(b) A health plan, third party administrator, or governmental agency is not required to provide coverage for the cost of an investigational drug, biological product, or device, or the cost of services related to the use of an investigational drug, biological product, or device under this chapter.
(c) This chapter does not require any governmental agency to pay costs associated with the use, care, or treatment of a patient with an investigational drug, biological product, or device.
(d) This chapter does not require a hospital or other health care facility to provide new or additional services, unless approved by the hospital or facility.
Last modified: May 3, 2021